Premium
Endometrial carcinoma recurring after hysterectomy. A study of 64 cases, with observations on effective treatment modalities and implications for alteration of primary therapy
Author(s) -
Long Robert T. L.,
Sala J. M.,
Spratt J. S.
Publication year - 1972
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197202)29:2<318::aid-cncr2820290208>3.0.co;2-f
Subject(s) - medicine , hysterectomy , radiation therapy , carcinoma , pelvic exenteration , endometrial cancer , primary treatment , treatment modality , surgery , oncology , cancer
The treatment of post‐hysterectomy, recurrent endometrial carcinoma is unsatisfactory. Survival is prolonged by combinations of high voltage external radiotherapy and transvaginal therapy or radium applications, and progestins and alkylating agents have proved to be of value as well. Pelvic exenteration is of little help to these patients. The magnitude of this problem demands more attention to the prevention of implantation in dealing with the initial operable tumor.